An open label single arm prospective clinical study on Vatagajankusharasa with Pippali Churna and Manjishta Kwatha as Anupana in Gridhrasi (Sciatica)
Background - Low backache is the 2nd most common reason for all physician visits and it is a condition that affects as many as 80-90% of people during their life time. Sciatica is a relatively common condition with a life time incidence varying from 13-40%. Gridhrasi in Ayurveda is a Rujapradhana Nanatmaja Vatavyadhi, which has similar presentation of sciatica intervenes with the functional ability of low back and lower limbs. Vata Gajankusha Rasa is a potent medicinal preparation, which in classics have mentioned can cure severe form of Gridhrasi in a week. The present study is taken up with the hypothesis that Vata Gajankusha Rasa with Manjishta Kwatha and Pippali Churna as Anupana would be effective in the management of Gridhrasi. Objective - To evaluate the effectiveness of Vatagajankusha Rasa with Pippali Churna and Manjishta Kwatha as Anupana in the management of Gridhrasi (sciatica). Method - Among 40 registered patients 36 of them completed the course of treatment. They were administered with Vatagajankusha Rasa (125mg) twice daily with Pippali Churna (3grams) and Manjishta Kwatha (15ml) as Anupana before food for a period of 7 days. For stastistical analysis subjective and objective parameters were assessed by Wilcoxon signed rank and McNemar test. Result - In the parameters of Gridhrasi, the medicine was found to be statistically significant in relieving the assessment parameters like Ruk, Toda, Sthambha, Aruchi, Gourava (p<0.001). In Objective parameters like SLR and Lessagues test, significant relief was observed after statistical analysis. Conclusion - Vatagajankusha Rasa with Pippali Churna and Manjishta Kwatha as Anupana is effective in the management of symptoms of Gridhrasi.
Acharya JT, editor. Charaka Samhita of Agnivesha, Sutrasthana, Ch. 20, Ver. 11. 4th ed. Varanasi: Chaukhambha Surbharati Prakashana; 1994. p. 113.
Acharya JT, editor. Charaka Samhita of Agnivesha, Chikitasthana, Ch. 28, Ver. 56-57. 4th ed. Varanasi: Chaukhambha Surbharati Prakashana; 1994. p. 619.
Paradakara HSS, Ashtanga Hrudayam with Sarvanga Sundaram commentary of Arunadutta and Ayurveda Rasayana of Hemadri. Nidana Sthana 15/54. 10thed. Varanasi (India): Chaukambha Orientalia; 2014. P.535
Acharya JT, editor. Sushruta Samhita of Sushruta, Nidansthana, Ch. 1, Ver. 74. 4th ed. Varanasi: Chaukhambha Prakashana;1980. p. 268.
www.wikipedia.org/wiki/Sciatica browsed on 10/12/2015,2.30pm.- Valat JP;Genevay, S; Marty, M; Rozenberg, S; Koes,B(April 2010).Sciatica best practice and research.Clinical rheumatology.
Paradakara HSS, Ashtanga Hrudayam with Sarvanga Sundaram commentary of Arunadutta and Ayurveda Rasayana of Hemadri. Sutra Sthana 12/9. 10thed. Varanasi (India): Chaukambha Orientalia; 2014. P.193.
Paradakara HSS, Ashtanga Hrudayam with Sarvanga Sundaram commentary of Arunadutta and Ayurveda Rasayana of Hemadri. Sutra Sthana 12/7. 10thed. Varanasi (India): Chaukambha Orientalia; 2014. P.193.
Verma A, A.K. Singh - A clinical & comparative study of vatgajankushras and sallaki tablet in the management of Gridhrasi with special reference to sciatica - International ayurvedic medical journal, (issn:2320 5091) (february, 2107) 5 (2).
G Vedhanayakai, Indian journal of experimental biology, vol 41, june 2003, pp649-651
Anarpatel, Journal of pharmaceutical science and research, vol 2 (12), 2010, 809-813
C.B. Jha, B.Bhattacharya, K.K.Narang, Bhasmas as natural nanaorobots: the bio relevant metal complex. J. Tradt Nat Med; 1(1): 2-9
Journal of Ayurveda and Integrated Medical Sciences (JAIMS) retains the copyright of the contents of this journal but grant the readers the right to use the contents with terms and conditions under a creative common attribution licenses 4 of Attribution, Share Alike and Non-commercial type (CC BY-NC-SA) that allows copy, distribute, display, and perform the work and make derivative works based on it only for non-commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.